France · Series A startup

Who invested in Ermium Therapeutics

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$13Mraised across 2 rounds since 2019, from 2 sources

$7.0MSeries A$6.3MSeries A
Latest round
Series A, $6.3MJun 2022
Biggest round
$7.0MSeries A · Sept 2019
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202020212022
$7.0MSeries A$6.3MSeries A
First round
Series A, $7.0M
Sept 2019
Biggest round
$7.0M
Series A · Sept 2019
Between rounds
2.8 years
from the last two

The rounds

  1. Jun 2022
    Series A$6.3M3 new

    Source recorded

  2. Sept 2019
    Series A$7.0M

    No investor was named in the report.

    Reported by European-biotechnology

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Idinvest PartnersPrivate equity1round
EurazeoPrivate equity1round
KurmaPartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ermium Therapeutics

Who invested in Ermium Therapeutics?

Ermium Therapeutics's investors include Idinvest Partners, Eurazeo and KurmaPartners.

How much has Ermium Therapeutics raised?

Ermium Therapeutics has raised $13M across 2 rounds since 2019.

When did Ermium Therapeutics last raise?

Ermium Therapeutics's most recent round was a Series A of $6.3M in Jun 2022.

What was Ermium Therapeutics's biggest round?

Ermium Therapeutics's largest round on record is $7.0M (Series A), in Sept 2019.

Who backed Ermium Therapeutics first?

Ermium Therapeutics's first round on record, in Jun 2022, was backed by Idinvest Partners, Eurazeo and KurmaPartners.

What stage is Ermium Therapeutics at?

Ermium Therapeutics's latest named round is a Series A, in Jun 2022.

Where is Ermium Therapeutics based?

Ermium Therapeutics is based in France.

Companies like Ermium Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.